XORTX Therapeutics (XRTX) Current Assets (2020 - 2026)
XORTX Therapeutics' (XRTX) quarterly Current Assets came in at $744416.0 in Q1 2026, down 64.61% YoY from $2.1 million in Q1 2025, and down 40.97% on a QoQ basis from $1.3 million in Q4 2025.
XORTX Therapeutics (XRTX) Current Assets (2020 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 7 years of Current Assets data on file, last reported at $744416.0 in Q1 2026.
- Quarterly Current Assets fell 64.61% year-over-year to $744416.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $744416.0 (down 64.61% YoY) and the FY2025 annual result came in at $1.3 million, down 52.89% from the prior year.
- Current Assets fell to $744416.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $10.9 million in Q4 2022 to a low of $744416.0 in Q1 2026.
- A 5-year average of $3.6 million and a median of $2.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets tumbled 32.1% — and 2026, when it sank 64.61%.
- Tracing XRTX's Current Assets over 5 years: stood at $10.9 million in 2022, then plunged by 62.56% to $4.1 million in 2023, then plunged by 34.21% to $2.7 million in 2024, then tumbled by 52.89% to $1.3 million in 2025, then slumped by 40.97% to $744416.0 in 2026.
- The last three Current Assets figures came in at $744416.0 (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 1.76 Bn |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | 744,416.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 744,416.00 |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 4.07 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Dec 31, 2020 | 1.58 Mn |